Clinical Trials Browser

KRAS G12V Mutant Advanced Epithelial Cancers × pembrolizumab × 1 year × Clear all

NCT05389514 2025-11-20

Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors

Temporarily not available

KRAS G12V Mutant Advanced Epithelial Cancers